๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN ยท Real-Time Price ยท USD
60.41
-1.01 (-1.64%)
At close: Nov 20, 2026, 4:00 PM EST
60.41
0.00 (0.00%)
After-hours: Nov 20, 2026, 4:04 PM EST

BioMarin Pharmaceutical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,6553,2212,8542,4192,0961,846
Revenue Growth
18.14%12.87%17.97%15.42%13.53%-0.76%
Gross Profit
1,9451,7011,5261,140943.41746.97
Operating Income
597.44650.73474.21185.7754.68-74.32
Net Income
-19.12348.9426.86167.65141.56-64.08
Earnings Per Share
-0.101.802.210.870.75-0.35
EPS Growth
--18.24%153.71%16.00%--

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
VOXZOGO
990.81926.92735.09469.88169.135.86
VIMIZIM
825.9792.05739.78701.05663.74623.15
NAGLAZYME
493.37485.4479.58420.29443.79380.45
PALYNZIQ
461.09433.31355.05303.92255.03237.47
BRINEURA
200.58186.4169.08161.89154.33128.03
ALDURAZYME
186.26208.51183.89131.25128.42122.77
KUVAN
94.6199.53120.9180.77227.58285.78
ROCTAVIAN
27.8435.6426.073.49--
Royalty and Other
38.2653.4944.4746.6954.0162.78
Revenue (Total)
3,6553,2212,8542,4192,0961,846

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
736.011,5611,1381,0741,2921,014
Total Debt
4,190642.87633.971,1341,1201,123
Net Cash (Debt)
-3,454917.74503.74-60.07171.63-109.51
Net Cash Growth
-82.19%----
Net Cash Per Share
-17.904.652.56-0.310.91-0.60

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
676.62827.99572.84159.26175.9304.54
Capital Expenditures
-118.75-103.04-85.42-96.69-120.96-95.58
Free Cash Flow
557.86724.96487.4262.5754.94208.96
Free Cash Flow Growth
-32.96%48.73%679.02%13.88%-73.71%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.21%52.81%53.49%47.14%45.01%40.46%
Operating Margin
16.35%20.20%16.62%7.68%2.61%-4.03%
Pretax Margin
1.19%14.98%18.98%7.79%7.14%-4.08%
Profit Margin
-0.52%10.83%14.96%6.93%6.75%-3.47%
FCF Margin
15.26%22.50%17.08%2.59%2.62%11.32%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-32.7229.35108.34135.87-
Forward PE
10.9112.3717.8638.9839.0085.79
P/FCF Ratio
21.0715.7525.70290.28350.0677.63
PS Ratio
3.223.544.397.519.188.79